Journal Information
Vol. 224. Issue 1.
Pages 1-9 (January 2024)
Vol. 224. Issue 1.
Pages 1-9 (January 2024)
Original article
Full text access
Systemic strengths and needs in palliative home care: exploring complexity
Fortalezas sistémicas y necesidades en atención paliativa domiciliaria: explorando la complejidad
X. Busquet-Durana,b,e,
Corresponding author

Corresponding author.
, B. Mateu-Carraleroa, J. Bielsa-Pascualb,c,e, L. Milian-Adriazolaa, N. Salamero-Turaa, P. Torán-Monserratb,d,e
a Programa d’Atenció Domiciliària Equip de Suport (PADES), Servei d’Atenció Primària Vallès Oriental, Institut Català de la Salut, Barcelona, Spain
b Unitat de Suport a la Recerca Metropolitana Nord (USR-MN), Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
c Instituto de Investigación Germans Trias i Pujol (IGTP), Badalona, Barcelona, Spain
d Departmento de Medicina, Facultad de Medicina, Universitat de Girona, Girona, Spain
e Grupo de Investigacion Multidisciplinar en Salud y Sociedad GREMSAS, Barcelona, Spain
This item has received
Article information
Full Text
Download PDF
Tables (4)
Table 1. HexCom complexity model: needs and strengths.
Table 2. Key characteristics stratified by patient. Place of death among patients in specialized home palliative care (N = 464).
Table 3. Bivariate logistic regression regarding circumstances at discharge (death at home) ( N = 464).
Table 4. Logistic regression model regarding circumstances at discharge (death at home) ( N = 464).
Show moreShow less

We aimed to investigate the relationship between systemic strengths and complexity in home care of end-of-life patients.


Quantitative descriptive longitudinal study of patients cared for at home by a palliative care team. Place of death was analyzed in relation to complexity, as determined by the HexCom complexity model after the initial home assessment. We used Pearson’s chi-square test to analyze the comparison of proportions.


Forty-six hundred patients (74.4% oncologic) with a mean age of 76.2 years (SD 13.2) participated. Fifty-three percent had complete or severe functional dependence, 30.8% were already bedridden in the first assessment, and 59.7% died at home. Strengths influenced place of death, specifically exosystem (team) strength (OR: 4.07 [1.92–8.63]), microsystem (both patient 0.51 [0.28−0.94]) and caregiver (OR: 3.90 [1.48–10.25]), and chronosystem, related to prediction of progressive course (OR: 2.22 [1.37–3.60]).


To improve care for end-of-life patients and their families, a systemic view of dying and death that includes both needs and strengths is necessary. In this sense, the systemic framework proposed by Bonfrenbrenner can be useful for clinical practice.

Palliative care
Needs assessment
Home care services
Place on death

Nos proponemos investigar la relación entre las fortalezas sistémicas y el lugar de muerte en atención domiciliaria de pacientes en final de vida.


Estudio cuantitativo descriptivo longitudinal de pacientes atendidos por un equipo domiciliario de cuidados paliativos. Se analizó la ubicación de la muerte en relación con la complejidad detectada tras la primera valoración domiciliaria usando el modelo de complejidad HexCom. Para la comparación de proporciones utilizamos la prueba de ji cuadrado de Pearson.


Participaron 464 pacientes (74,4% oncológicos), edad media 76,2 años (DE: 13,2). El 53% presentaban dependencia funcional total o severa, el 30,8% estaban ya encamados en la primera valoración y el 59,7% fallecieron en domicilio. Las fortalezas influyen en el lugar de muerte, sobre todo la fortaleza del exosistema (equipo) (OR: 4,07 [1,92–8,63]), la del microsistema (tanto la fortaleza del paciente (0,51 [0,28–0,94]) como de cuidador (OR: 3,90 [1,48–10,25]), y la del cronosistema, relativo a la previsión de un curso progresivo (OR: 2,22 [1,37–3,60]).


Para mejorar la asistencia a los pacientes en situación de final de vida y sus familias es necesaria una mirada sistémica del morir y de la muerte que incluya tanto necesidades como fortalezas. En este sentido, el marco sistémico propuesto por Bonfrenbrenner puede ser de utilidad para la práctica clínica.

Palabras clave:
Cuidados paliativos
Evaluación de necesidades
Servicios de atención de salud a domicilio
Lugar de muerte
Full Text

The goal of palliative care is to improve the quality of life of patients and their family members as they confront the problems inherent to a life-threatening illness.1 In this situation, psychological, social, and spiritual health are considered equally important to physical health.2 Based on the works of Ferris et al.,3 a model of care focused on needs with the ultimate aim of alleviating suffering has become established internationally. Care at the end of life is care for suffering; this suffering emerges when something is perceived as a major threat and, at the same time, one does not have sufficient resources to face it.4,5 In this sense, rather than focusing on threatened needs, attention should be focused on detecting and reinforcing the strengths of the system and, thus, increasing the sense of control. Focusing care only on people’s needs promotes their infantilization.6 It has been suggested that this phenomenon be called “care blinders.”

Home care for severe and/or near-death patients is not only limited by the more or less sophisticated healthcare resources provided by the hospital and health centers, but also by the involvement of family and formal caregivers, who are often not available.7 In our setting, death has moved from a family and community setting to being primarily the domain of health systems.2 Relationships and networks have been replaced by professionals and protocols which focus on needs, and primarily biological aspects.8 It is known that reductionism and compartmentalization can potentially be counterproductive in the challenge of managing complex problems.9

Following the conceptual model of complexity’s role in the care of patients with multiple chronic diseases,10 complexity of care can be understood as the persistence of unease/suffering despite the care received. This depends on individual variables that arise from the patient’s life experience and on the capacity for care of the healthcare team assessing him/her.11 This means that in clinical practice, complexity would be equivalent to the team’s difficulty in responding to the patient’s specific needs at any given time. Previous studies have been able to objectify how complexity in home care is related to location of death such that probability of death in the hospital is greater in more complex cases12 and that there is a linear association between complexity and location of death in the hospital.13

Among the palliative care complexity classification systems,14 only the HexCom-Clin model includes a specific section for the detection and assessment of strengths. It is based on the five ecological systems proposed by Bronfenbrenner15: microsystem (person, needs, and characteristics), chronosystem (dynamic influences of time), mesosystem (interactions with family/health professionals), exosystem (palliative care services/systems), and macrosystem (social influences) (Table 1). This categorization has undergone a qualitative16 and quantitative17 validation process.

Table 1.

HexCom complexity model: needs and strengths.

NEEDS: identifies the patient’s areas of discomfort and relates it to the possibility of a response by the department.
Levels of complexity and interpretation:
L — low (little difficulty). Guarantee of being able to address the situation with the department’s resources.
M — medium (moderate difficulty). Guarantee of handling the situation with the support of other professionals and/or specialized teams.
H — high (refractory difficulty). Little possibility of change. Accompaniment and/or probable referral to another resource/level of care is required
Clinical  Physical discomfort due to symptoms (pain, dyspnea), refractory lesions (malignant ulcer), or therapeutic difficulty (adherence or access to drugs/techniques) 
Psychoemotional  Maladaptive emotional unease (intense, persistent emotions that interfere with relationships and functionality), inflexible personality traits (poorly adaptive), psychopathological profile 
Spiritual  Deep unease with a feeling of a biographical disruption, lack of meaning (personal, vital, suffering), loneliness (unwanted, isolation due to breakdown of relationships), feeling of guilt, impossibility to forgive (oneself, others), panic about the future (death itself or separation from loved ones), feeling of injustice 
Social-family  Unease in the caregiver/patient relationship, insufficient care, no resources, no caregiver 
Ethics  Unease due to information management, clinical decisions/adequacy of therapeutic effort (ATE), desire for hastened death (DHD) 
Direct relationship with death/dying process  Unease due to problematic location of dying. Maladaptive denial of the final days of life (FDL), traumatic FDL difficult sedation (due to practice, indication, understanding). Risk factors for complicated grief 
STRENGTHS: identifies the systemic source of strength and relates it to the possibility of reinforcing them by the department.
Levels of strength and interpretation:
L — Low (absent): There are no strengths or they are not used. Significant difficulty in being able to reinforce them.
M — Medium (precarious): Fragile support that must be validated, preserved, and strengthened as a priority.
H — High (consistent): Firm support that is unlikely to change during the course of the disease.
Microsystem  Individuals: the patient and his/her caregivers  PATIENT: strength of the patient (values, mental capacity, resilience/adaptability, preferences/priorities) 
    CAREGIVER: strength of family caregivers (values, mental/physical capacity, resilience/adaptability, extensive network) 
MesosystemInteractions: patient interaction with their relationship network and professional networkTIES: strength of family and/or community ties (tone of caring, organizational capacity, etc.) 
PROFESSIONAL TIES: strength of ties with referring professionals (primary care physician/nurse, specialist) 
FINANCES: financial strength 
ChronosystemTime: changes over timePENDING ISSUES: having pending issues that cause concern (legacy, finances, bequest, ties, etc.) 
PROGRESSIVE COURSE: anticipating a progressive course of the disease without abrupt changes and without changes in the caregiving environment 
Exosystem  Team: team competence  TEAM: the strength and competence of the team to meet the needs of the patient/family (interdisciplinary nature, training, communication, community integration, continuity, and consensus on the therapeutic objective) 
Macrosystem  Resources: availability of health and social-health services/resources  SOCIAL-HEALTH RESOURCES: sufficient provision and accessibility to social-health services and/or resources to meet the patient's needs (continuity of care, home help service, dependency law, places in residential facilities, hospitalization or social-health admission, radiotherapy units, pain clinic, day hospital, etc.) 

This work aims to investigate the relationship between place of death and the strengths of the patient and his/her care environment. The specific objectives are: 1) link the place of death to the level of strength. 2) Determine which subtypes of strengths have the greatest influence on the place of death. 3) Link the place of death to the level of need.

Patients and methods

This work is a quantitative, descriptive, longitudinal, cohort study.

Patients attended to by a home care support team in the period from January 1, 2019 to December 31, 2021 were analyzed. This team, created in 1992, comprises medical, nursing, psychology and social work professionals. Its coverage area includes a total of 193,520 inhabitants (urban and rural). It reports to the primary care management and does not have direct access to a palliative care unit.

Inclusion criteria

Patients at the end of life cared for at home and those already deceased in whom the HexCom-Clin model was used as a tool for assessing complexity after the first visit.

Exclusion criteria

Patients whose HexCom-Clin record was not completed. Patients cared for at nursing homes, patients in the bereavement program or volunteer program exclusively, and those attended to for a percutaneous gastrostomy replacement were excluded.

Definition of variables

  • Sociodemographics: age, sex, partner as main caregiver (yes/no), family worker (yes/no) (Professional who cares for the patient and provides the care necessary for performing activities of daily living).

  • Clinical: main diagnosis (oncologic/non-oncologic), performance status (degree of dependence: total/severe with Barthel ≤60), cognitive status (mild/moderate impairment: >2 errors Pfeiffer), prognosis (Palliative Performance Status ≤40 bedridden).

  • Care: circumstances at discharge (death at home: yes/no).

Complexity variables

  • Needs: clinical, psychoemotional, spiritual, social-familial, ethical, and in relation to dying (low (L), medium (M), or high (H) complexity). For the analysis, high and medium complexity were grouped and compared to low complexity.

  • Strengths: patient microsystem, caregiver microsystem, family ties mesosystem, professional ties mesosystem, economic strength mesosystem, pending issues chronosystem, progressive course chronosystem, team exosystem, and social-health structure macrosystem (low (L), medium (M), or high (H)). For the analysis, low and medium strength were grouped and compared to high strength.

Data analysis

Pearson’s chi-square test was used to determine independence or association between two variables through the comparison of proportions. On the bivariate logistic regression, the odds ratio (OR) with its corresponding confidence intervals and 95% significance was used to determine the weight of each variable in relation to the study variable (death at home: yes or no). On the multivariate logistic regression in a first saturated model, all factors that were found to be significant on the bivariate analysis or which had p ≤ 0.100 were included. Next, those that were not significant were eliminated until the final model was reached. The level of significance was p < 0.05. All analyses were performed using the SPSS statistical package for Windows, version 25.0.

Ethics committee approval

The study was approved by the Clinical Research Ethics Committee of the Jordi Gol University Institute for Research on Primary Care (IDIAP, for its initials in Spanish) (registration number 4R19/125). All participants read and signed an informed consent form.


Of the 930 new patients attended to during the study period, 464 patients met the inclusion/exclusion criteria (49.89%). The mean age was 76.2 (SD 13.2) years. Most were male (58%) and had oncologic disease (74.4%). Fifty-three percent had total or severe functional dependence (Barthel ≤60), 30.8% were already bedridden at the initial assessment (PPS ≤40), 70.9% had no cognitive impairment (Pfeiffer ≤2 errors), the main caregiver was the partner in 46.8% of cases, and 28.7% had the help of a family worker. A total of 277 patients (59.7%) died at home.

Table 2 shows that, regarding the general variables, patients who are young, male, and have cancer die in the hospital more often (p < 0.001). On the other hand, patients with functional or cognitive impairment and those who have a family worker died at home more often (p < 0.001). In regard to the needs detected in the first visit, it can be seen that all the areas of need are related to death in the hospital except for the area of psychological need (p = 0.462). In regard to strengths, strength in each of the subareas is related to death at home except for the strength of patient, which is related to death in the hospital (p = 0.000) and the strength of macrosystem, which appears to be unrelated to place of death (p = 0.260).

Table 2.

Key characteristics stratified by patient. Place of death among patients in specialized home palliative care (N = 464).

  Total  Death at homep Value 
    No  Yes   
    187 (40.3%)  277 (59.7%)   
General variables
Age (mean and SD)  76.2 (13.2%)  72.8 (13.0)  78.4 (12.8)  <0.001 
Female gender  195 (42.0%)  62 (33.2%)  133 (48.0%)  0.001 
Performance status (Barthel): total dependency, severe ≤60  247 (53.2%)  66 (35.3%)  181 (65.3%)  <0.001 
Cognitive status (Pfeiffer): no cognitive impairment ≤2 errors  370 (79.7%)  132 (70.6%)  238 (85.9%)  <0.001 
Prognosis (Palliative Performance Status) bedridden ≤40  143 (30.8%)  26 (13.9%)  117 (42.2%)  0.000 
Caregiver: partner  217 (46.8%)  93 (49.7%)  124 (44.8%)  0.169 
Family worker  133 (28.7%)  37 (19.8%)  96 (34.7%)  <0.001 
Type of disease: oncological  345 (74.4%)  158 (84.5%)  187 (67.5%)  <0.001 
Needs (high and medium complexity)
Clinical need  231 (49.8%)  111 (59.4%)  120 (43.3%)  <0.001 
Psychological need  263 (56.7%)  105 (56.1%)  158 (57.0%)  0.462 
Spiritual need  194 (41.8%)  94 (50.3%)  100 (36.1%)  0.002 
Social-familial need  311 (67.0%)  144 (77.0%)  167 (60.3%)  <0.001 
Ethical need  102 (22.0%)  49 (26.2%)  53 (19.1%)  0.046 
Death need  320 (69.0%)  171 (91.4%)  149 (53.8%)  <0.001 
Strengths (high strength)
Patient microsystem strength  324 (69.8%)  151 (80.7%)  173 (62.5%)  <0.001 
Caregiver microsystem strength  427 (92.0%)  161 (86.1%)  266 (96.0%)  <0.001 
Family ties mesosystem strength  435 (93.8%)  168 (89.8%)  267 (96.4%)  0.004 
Professional ties mesosystem strength  429 (92.5%)  165 (88.2%)  264 (95.3%)  0.004 
Financial strength mesosystem strength  404 (87.1%)  150 (80.2%)  254 (91.7%)  <0.001 
Pending issues chronosystem strength  370 (79.7%)  127 (67.9%)  243 (87.7%)  <0.001 
Progressive course chronosystem strength  289 (62.3%)  82 (43.9%)  207 (74.7%)  <0.001 
Exosystem (team) strength  396 (85.3%)  139 (74.3%)  257 (92.8%)  <0.001 
Macrosystem (social-health structure) strength  405 (87.3%)  166 (88.8%)  239 (86.3%)  0.260 

Notes: Performance status (degree of dependence: total/severe with ≤60 Barthel). Cognitive status (no cognitive impairment ≤2 errors Pfeiffer). Prognosis (Palliative Performance Status: Bedridden with ≤40 PPS). Needs: for the analysis, high and medium complexity were grouped and compared to low complexity. Strengths: for the analysis, low and medium strength were grouped and compared to high strength.

Table 3 shows the results of the bivariate analysis. As can be seen, performance status was the variable with the greatest weight in dying at home, both in relation to the Barthel Index OR 3.46 (2.34–5.10) and Palliative Performance Status (PPS) OR 4.53 (2.81–7.30), followed by cognitive impairment OR 2.54 (1.60–4.04, p = 0.000), and having a family worker OR 2.15 (1.39–3.33). On the other hand, it is observed that those who die at home less often are individuals with cancer OR 0.38 (0.24−0.61) or women OR 0.54 (0.37−0.79). Regarding the areas of need, it was found that the area related to death—which includes difficulties in planning the location, management of the final days of life, and the presence of risk factors for grief—was most related to dying outside the home OR 0.11 (0.06−0.19), followed by the area of social-familial need 0.45 (0.30−0.69). As for the strengths, the exosystem—that is, the team that cares for the patient itself—held the most weight, with OR 4.44 (2.53–7.78), followed by the strength of caregiver, OR 3.91 (1.88–8.12). The strength of the patient was the only subarea that behaved inversely, being linked to death outside the home OR 0.40 (0.26−0.61).

Table 3.

Bivariate logistic regression regarding circumstances at discharge (death at home) ( N = 464).

  β  OR (95% CI)  p 
General variables
Age  0.033  1.03 (1.02–1.05)  <0.001 
Gender: female  −0.622  0.54 (0.37–0.79)  0.002 
Performance status (Barthel): total dependency, severe ≤60  1.240  3.46 (2.34–5.10)  <0.001 
Cognitive status (Pfeiffer): Mild, moderate, severe impairment >2 errors  0.933  2.54 (1.60–4.04)  <0.001 
Prognosis (Palliative Performance Status) bedridden ≤40  1.510  4.53 (2.81–7.30)  <0.001 
Caregiver: partner  −0.199  0.82 (0.56–1.19)  0.293 
Family worker  0.766  2.15 (1.39–3.33)  0.001 
Type of disease: oncologic  −0.964  0.38 (0.24–0.61)  <0.001 
Needs (high and medium complexity)
Clinical need  −0.648  0.52 (0.36–0.76)  0.001 
Psychological need  0.036  1.04 (0.71–1.51)  0.849 
Spiritual need  −0.582  0.56 (0.38–0.82)  0.003 
Social-familial need  −0.791  0.45 (0.30–0.69)  <0.001 
Ethical need  −0.406  0.67 (0.43–1.04)  0.072 
Death need  −2.217  0.11 (0.06–0.19)  <0.001 
Strengths (high strength)
Patient microsystem strength  -0.925  0.40 (0.26–0.61)  <0.001 
Caregiver microsystem strength  1.362  3.91 (1.88–8.12)  <0.001 
Family ties mesosystem strength  1.105  3.02 (1.37–6.65)  0.006 
Professional ties mesosystem strength  0.996  2.71 (1.33–5.52)  0.006 
Financial strength mesosystem strength  1.002  2.72 (1.56–4.76)  <0.001 
Pending issues chronosystem strength  1.217  3.38 (2.11–5.41)  <0.001 
Progressive course chronosystem strength  1.331  3.79 (2.55–5.63)  <0.001 
Exosystem (team) strength  1.490  4.44 (2.53–7.78)  <0.001 
Macrosystem (social-health structure) strength  -0.229  0.80 (0.45–1.40)  0.431 

Notes: Performance status (degree of dependence: total/severe with ≤60 Barthel). Cognitive status (mild, moderate, severe impairment >2 errors Pfeiffer). Prognosis (Palliative Performance Status: bedridden with ≤40 PPS). Needs: For the analysis, high and medium complexity were grouped and compared to low complexity. Strengths: for the analysis, low and medium strength were grouped and compared to high strength.

Table 4 shows the saturated and final logistic regression model: Dying at home was related to being bedridden (PPS ≤40) OR 2.68 (1.46–4.92), having cognitive impairment (Pfeiffer >2 errors) OR 1.93 (1.10–3.40), and female gender OR 1.63 (1.01–2.62). Regarding gender, it is important to mention that the interaction caused by the variables within the model inverted its β coefficient and, although it lost statistical power in its p value, it continued to be statistically significant within the model. On the other hand, not dying at home was associated with cancer OR 0.47 (0.24−0.89). As for the areas of need, the only one that remained in the final model was the area in relation to death OR 0.19 (0.10−0.35), but with a very significant weight. Finally, the strengths that influenced the place of death were the strengths of exosystem (team) OR 4.07 (1.92–8.63), microsystem (both patient strength 0.51 (0.28−0.94) and caregiver strength OR 3.90 (1.48–10.25) but in an inverse manner), and chronosystem, regarding anticipation of a progressive course without abrupt changes OR 2.22 (1.37–3.60).

Table 4.

Logistic regression model regarding circumstances at discharge (death at home) ( N = 464).

  Saturated model
  β  OR (95% CI)  p 
General variables
Family worker  0.121834  1.13 (0.61–2.08)  0.695 
Performance status (Barthel): total dependency, severe ≤60  0.483722  1.62 (0.92–2.86)  0.095 
Cognitive status (Pfeiffer): mild, moderate, severe impairment >2 errors  0.601199  1.82 (1.02–3.28)  0.044 
Prognosis (Palliative Performance Status): bedridden ≤40  0.951229  2.59 (1.32–5.08)  0.006 
Age  0.008225  1.01 (0.99–1.03)  0.436 
Gender: female  0.435489  1.55 (0.94–2.55)  0.088 
Type of disease: oncological  −0.48355  0.62 (0.30–1.27)  0.189 
Clinical need  −0.14354  0.87 (0.531.41)  0.562 
Social-familial need  0.446881  1.56 (0.86–2.85)  0.145 
Death need  −1.67685  0.19 (0.09–0.38)  <0.001 
Ethical need  −0.1558  0.86 (0.48–1.51)  0.592 
Spiritual need  0.351631  1.42 (0.84–2.40)  0.187 
Strength patient microsystem  −0.56756  0.57 (0.29–1.11)  0.100 
Caregiver microsystem strength  1.346329  3.84 (1.32–11.19)  0.014 
Family ties mesosystem strength  −0.05389  0.95 (0.27–3.36)  0.933 
Professional ties mesosystem strength  0.349969  1.42 (0.51–3.97)  0.505 
Financial strength mesosystem strength  0.446376  1.56 (0.73–3.32)  0.246 
Pending issues chronosystem strength  0.40626  1.50 (0.79–2.86)  0.217 
Progressive course chronosystem strength  0.691044  2.00 (1.18–3.38)  0.010 
Exosystem (team) strength  1.294698  3.65 (1.63–8.17)  0.002 
Constant  −3.39814  0.03 (0.00–0.00)  0.012 
Final model  β  OR (95% CI)  p 
Cognitive status (Pfeiffer): mild, moderate, severe impairment >2 errors  0.659005  1.93 (1.10–3.40)  0.022 
Palliative performance status: bedridden ≤40  0.986832  2.68 (1.46–4.92)  0.001 
Gender: female  0.486768  1.63 (1.01–2.62)  0.045 
Type of disease: oncological  −0.76062  0.47 (0.24–0.89)  0.021 
Death need  −1.65019  0.19 (0.10–0.35)  <0.001 
Patient microsystem strength  −0.66743  0.51 (0.28–0.94)  0.032 
Caregiver microsystem strength  1.360469  3.90 (1.48–10.25)  0.006 
Progressive course chronosystem strength  0.796464  2.22 (1.37–3.60)  0.001 
Exosystem (team) strength  1.403538  4.07 (1.92–8.63)  <0.001 
Constant  −1.1415  0.32 (0.00–0.00)  0.097 

Notes: Performance status (degree of dependence: total/severe with ≤60 Barthel). Cognitive status (mild, moderate, severe impairment >2 errors Pfeiffer). Prognosis (Palliative Performance Status: bedridden with ≤40 PPS). Needs: for the analysis, high and medium complexity were grouped and compared to low complexity. Strengths: for the analysis, low and medium strength were grouped and compared to high strength.


These results suggest that systemic strengths strongly influence the complexity of care in palliative home care. Above all, the strength of exosystem (team) OR 4.07 (1.92–8.63), microsystem (both the strength of the patient 0.51 (0.28−0.94) and the caregiver OR 3.90 (1.48–10.25), and chronosystem, regarding anticipation of a progressive course OR 2.22 (1.37–3.60) had an influence.

The authors are not aware of any studies regarding strengths to support or refute these results. However, the data found in regard to the general variables related to the place of death seem to reinforce them. In this regard, various studies have shown how performance and cognitive status, age, and type of disease are related to dying at home or not.18–21 It seems obvious that the strength of team (exosystem) and the ability to anticipate a disease without abrupt changes (chronosystem) would favor death at home. In this regard, Alonso-Babarro, A et al. found that having a home palliative care team considerably decreased the risk of dying in the hospital (OR 0.4, 0.2−0.6).22 Furthermore, Gomes et al.23 noted that abrupt changes in the course of a disease favored in-hospital death. As for the microsystem—that is the strengths of the patient and the caregiver—it seems that they would act inversely: if the strength is the caregiver, he/she will probably die at home, and if it is the patient, he/she will likely die in the hospital.

This could possibly indicate that we are in a setting that does not accept death and dying and that a patient with enough strength will continue to fight to the end.24,25 On the other hand, we are in a society in which information is still often withheld from the patient and the family member is the one with more information and, thus, decision-making power. In this regard, Costa et al. found that coherence in decision making between the patient and caregiver was the strongest predictor of place of death.26 Another explanation could be that if the strength is the patient, he/she would want to protect his/her care environment and therefore would prefer not to die at home. In any case, these results are preliminary and exploratory; they will need to be explored further, perhaps using qualitative methods.

This study has various limitations. The first limitation is that the opinion of the patient and his/her care environment was not considered, nor was that of the different actors in the system, such as the health and social primary care professionals involved or the professionals in the hospital units. However, the apparent validity demonstrated with the HexCom-Clin model16 and the corresponding reliability studies17 lend a certain degree of strength to the results. Likewise, the evaluation team is an interdisciplinary team with extensive healthcare and research experience.

The second limitation is more conceptual. Despite being a topic of growing interest, the conceptualization of complexity in palliative care is not well established.14 This work is based on the hypothesis that the greater the complexity of care, the easier it is to die in the hospital. Clinical practice and previous studies do indeed suggest this,12,27 but it remains a hypothesis and a simplification. The paradigm of complexity focuses on the interaction of variables. These results suggest that more than one particular area of strength, it is the interaction between the different strengths that is more important.

Finally, this study encompasses the COVID-19 period, in which the pandemic severely compromised the various health services.28,29 At that point, home care was considerably limited and the location of the death was changed and determined by factors such as the availability of services and difficulties in social-familial accompaniment.30,31 One of the anomalies observed is the lack of a HexCom record in some of the patients in this period. It is also true that this opens up a future line of research into differences in regard to complexity and resources in the COVID-19 era.32,33

Home teams providing end of life care for a patient must have a comprehensive, realistic vision,34 and this reality includes both the needs, which will always be increasing, and the strengths, which must be reinforced.35 The analysis of strengths in the first visit can help in planning the place of death. Assessing the strength of caregiver (microsystem), the team itself (exosystem), and foreseeing a progressive disease course without disruptions (chronosystem) may have a greater influence on planning for death at home than the needs detected at that time. However, complexity is a dynamic concept that will change over time as the disease progresses and is the result of the interaction among the different variables. On the contrary, it would be advisable to have a bed in a palliative care unit in advance if the individual is a patient with cancer without functional dependence. Ultimately, the aim is to ensure that people can die at home, limiting transfers to hospitals as much as possible7 and preventing the patient’s dying moments from occurring in the hospital to the extent it is possible.34

In future studies, it is essential to include the different care resources where the patient may die and which intervene in the process (nursing homes, social-health care, acute care hospital) as well as the variable of time of care, which other studies have shown significantly influences the place of death.13 On the other hand, it would be interesting to delve deeper into the role of the gender variable in regard to strengths and its impact on complexity, taking into account both the strengths of the patient and the caregiver.


In conclusion, in order to improve care for patients at the end of life and their families, a systemic view of death and dying2 that includes both needs and strengths is needed. In this sense, the systemic framework proposed by Bonfrenbrenner may be useful in clinical practice.15

Ethical considerations

The study was approved by the Clinical Research Ethics Committee of the Jordi Gol University Institute for Research on Primary Care (CEIC IDIAP, for its initials in Spanish) (registration number 4R19/125). All participants read and signed an informed consent form.


This study received partial funding from the JGol University Institute for Research on Primary Care (IDIAP) (4R17/053) and a research grant for the principal investigator (XB).

Conflicts of interest

All authors declare that they have no known financial interests or personal relationships that may appear to influence the work presented in this article.

Availability of databases and material for replication

The Jordi Gol IDIAP has no mechanism in place to store anonymized databases in public repositories. The data are not publicly available due to privacy restrictions. However, the properly anonymized databases can be made available to individuals through express request made to the principal investigator of the project and corresponding author of this article, Dr. Xavier Busquet-Duran (


To Rosa María García, of GREMSAS, and to all the members of the PADES Granollers team who participated in the study: Joana Llobera-Estrany, Ana Isabel López-García, Eva María Jiménez-Zafra, Olga Bosch-de la Rosa, Anna Moragas-Roca, Susana Martin Moreno, Emilio Martínez-Losada, Silvia Crespo-Ramírez, Eda Sara Persentil Viure, and María Jesús Micó.

World Health Organization. Palliative-Care. Published 2022. [Accessed 31 August 2023]. Available from:
L. Sallnow, R. Smith, S.H. Ahmedzai, A. Bhadelia, C. Chamberlain, Y. Cong, et al.
Report of the Lancet Commission on the value of death: bringing death back into life.
F.D. Ferris, H.M. Balfour, K. Bowen, et al.
A model to guide patient and family care.
J Pain Symptom Manage, 24 (2002), pp. 106-123
R. Bayés, P. Arranz, J.B.P. Barbero.
Propuesta de un modelo integral para una intervención terapéutica paliativa.
Med Paliativa, 3 (1996), pp. 114-121
J. Maté, D. Mateo, R. Bayés, C. Casas.
Elaboración y propuesta de un instrumento para la detección del malestar emocional en enfermos al final de la vida.
Psicooncología, 6 (2009), pp. 507-518
C. Gilligan.
La ética del cuidado.
Fundació Víctor Grífols i Lucas, (2013),
V.J. González Ramallo, M.M. Gallego Alonso-Colmenares.
Dying at home, a reasonable alternative to hospitalization.
Rev Clin Esp, 218 (2018), pp. 296-297
J. Díez-Manglano, S. Isasi de Isasmendi Pérez, M. Rubio Gómez, et al.
Cuidados en los últimos días de vida en los pacientes hospitalizados en medicina interna.
Rev Clín Esp, 219 (2019), pp. 107-115
S.D. Halpern.
Toward evidence-based end-of-life care.
N Engl J Med, 373 (2015), pp. 2001-2003
D. Grembowski, J. Schaefer, K.E. Johnson, et al.
A conceptual model of the role of complexity in the care of patients with multiple chronic conditions.
N. Codorniu, A. Tuca.
Complexity levels of interventions in a hospital support team: descriptive study about prevalence, clinical characteristics and team organisation for each level. 3rd European Association for Palliative Care Research Congress-Stresa, Italy 2004. EAPC Abstracts., ed..
Palliat Med, 18 (2004), pp. 303-393
A. Tuca, M. Gómez-Martínez, A. Prat.
Predictive model of complexity in early palliative care: a cohort of advanced cancer patients (PALCOM study).
Support Care Cancer, 26 (2018), pp. 241-249
X. Busquet-Duran, E. Jimenez-Zafra, M. Tura-Poma, O. Bosc-de la Rosa, J. Manresa-Dominguez, P. Toran-Monserrat.
Trayectorias de complejidad en final de vida: un estudio multicéntrico prospectivo observacional longitudinal.
Med Paliativa, 28 (2021), pp. 13-22
M. Grant, E. de Graaf, S. Teunissen.
A systematic review of classifications systems to determine complexity of patient care needs in palliative care.
Palliat Med, 35 (2021), pp. 636-650
S. Pask, C. Pinto, K. Bristowe, et al.
A framework for complexity in palliative care: a qualitative study with patients, family carers and professionals.
Palliat Med, 32 (2018), pp. 1078-1090
X. Busquet-Duran, E.M. Jiménez-Zafra, M. Tura-Poma, et al.
Assessing face validity of the Hexcom model for capturing complexity in clinical practice: a Delphi study.
X. Busquet-Duran, M. Esteban-Perez, J.M. Manresa-Domínguez, S.M. Moreno, L. Leston-Lado, P. Torán-Monserrat.
Intra-rater reliability and feasibility of the HexCom advanced disease complexity assessment model.
Aten Primaria, 54 (2022), pp. 102343
L. Pivodic, K. Pardon, L. Morin, et al.
Place of death in the population dying from diseases indicative of palliative care need: a cross-national population-level study in 14 countries.
J Epidemiol Community Health, 70 (2016), pp. 17-24
M.J. Cabañero-Martínez.
Lugar de fallecimiento de las personas con enfermedades susceptibles de cuidados paliativos en las diferentes comunidades autónomas de España.
An Sist Sanit Navar, 43 (2020), pp. 69-80
J.M. Davies, K.E. Sleeman, J. Leniz, et al.
Socioeconomic position and use of healthcare in the last year of life: a systematic review and meta-analysis.
PLoS Med, 16 (2019), pp. e1002782
R.I. Jordan, M.J. Allsop, Y. ElMokhallalati, et al.
Duration of palliative care before death in international routine practice: a systematic review and meta-analysis.
A. Alonso-Babarro, E. Bruera, M. Varela-Cerdeira, et al.
Can this patient be discharged home? Factors associated with at-home death among patients with cancer.
J Clin Oncol, 29 (2011), pp. 1159-1167
B. Gomes, N. Calanzani, M. Gysels, S. Hall, I.J. Higginson.
Heterogeneity and changes in preferences for dying at home: a systematic review.
BMC Palliat Care, 12 (2013), pp. 7
T.A. Schroepfer.
Mind frames towards dying and factors motivating their adoption by terminally ill elders.
J Gerontol B Psychol Soc Sci, 61 (2006), pp. S129-S139
F. Saeed, M. Hoerger, S.A. Norton, E. Guancial, R.M. Epstein, P.R. Duberstein.
Preference for palliative care in cancer patients: are men and women alike?.
J Pain Symptom Manage, 56 (2018), pp. 1-6
V. Costa, C.C. Earle, M.J. Esplen, et al.
The determinants of home and nursing home death: a systematic review and meta-analysis.
BMC Palliat Care, 15 (2016), pp. 8
X. Busquet-Duran, E.M. Jiménez-Zafra, J.-M. Manresa-Domínguez, et al.
Describing complexity in palliative home care through HexCom: a cross-sectional, multicenter study.
J Multidiscip Healthc, 13 (2020), pp. 297-308
X. Gómez-Batiste, J.P. Leiva, A. Tuca, et al.
Organización paliativa durante la pandemia de la COVID-19 y propuestas para la adaptación de los servicios y programas de cuidados paliativos y de atención psicosocial ante la posibilidad de reactivación de la pandemia y época pos-COVID-19.
Med Paliativa, 27 (2020), pp. 242-254
R. García Caballero, B. Herreros.
Areas for improvement in end-of-life care.
Rev Clin Esp, 221 (2021), pp. 341-342
V. Buscemi, M. López, O. Bosch, et al.
Aprendiendo de la experiencia del duelo en el contexto de la pandemia por el COVID-19.
Med Paliativa, 28 (2021), pp. 166-176
I. Bullich-Marín, E. Costas-Muñoz, N. López-Matons.
Cuidados paliativos al final de la vida en tiempos de pandemia: la experiencia del PADES-COVID.
Med Clin (Barc), 158 (2022), pp. 239-240
E.M. Sanz Peces, V. Vázquez Ramos, J. Tejero González, et al.
Impacto de la pandemia por COVID-19 en pacientes con necesidades paliativas atendidos por un equipo de soporte de atención domiciliaria.
Med Paliativa, 29 (2022), pp. 88-95
Y.A. Rubio, C. Jiménez-Rojas, F.J. Gómez-Pavón.
Efectos de la pandemia por COVID-19 en la actividad de una unidad de cuidados paliativos.
Med Clin (Barc), 156 (2021), pp. 520-521
P. Conthe.
El médico clínico ante el paciente en el final de sus días.
Rev Clin Esp, 218 (2018), pp. 15-16
K.I. Stajduhar, L. Funk, D. Roberts, et al.
Home care nurses’ decisions about the need for and amount of service at the end of life.
J Adv Nurs, 67 (2011), pp. 276-286
Copyright © 2023. The Authors
Revista Clínica Española (English Edition)
Article options
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?